Author:
Vaz Jennifer,Piver Rachael,Brzezinska Bogna,Suhner Jessa,Sareddy Sneha,Vuppala Priyanka,Vernon Marlo,Xu Hongyan,Rungruang Bunja,Johnson Marian,Higgins Robert V.,Ghamande Sharad,Richardson Katherine P.,McIndoe Richard,Purohit Sharad,Mysona David
Reference19 articles.
1. Immunotherapy in gynecological cancers;Lorusso;Explor. Target Antitumor. Ther.,2021
2. Immunotherapy through the years;Eno;J. Adv. Pract. Oncol.,2017
3. Pembrolizumab for persistent, recurrent, or metastatic cervical Cancer;Colombo;N. Engl. J. Med.,2021
4. Pembrolizumab plus chemotherapy in advanced endometrial Cancer;Eskander;N. Engl. J. Med.,2023
5. Immunotherapy in Gynecologic Cancers: What we Know Now and where we Are Headed;Levinson,2019